11/14/2024
6:50 PM | Fate Therapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SC 13G/A | |
10/25/2024
8:37 PM | Boxer Capital Management, LLC (Filed by)
Fate Therapeutics (Subject)
| Form SC 13G/A | |
10/21/2024
3:11 PM | BlackRock, Inc. (Filed by)
Fate Therapeutics (Subject)
| Form SC 13G/A | |
08/30/2024
3:21 PM | Fate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2024
3:01 PM | Fate Therapeutics (Issuer)
Xu Yuan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
9:34 AM | Fate Therapeutics (Subject)
Xu Yuan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/31/2024
4:59 PM | Fate Therapeutics (Issuer)
Mozaffarian Neelufar (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
|
07/31/2024
5:00 PM | Fate Therapeutics (Issuer)
TAHL CINDY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/31/2024
5:01 PM | Fate Therapeutics (Issuer)
Mozaffarian Neelufar (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/31/2024
5:05 PM | Fate Therapeutics (Issuer)
Valamehr Bahram (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/31/2024
3:03 PM | Fate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/11/2024
5:19 PM | Fate Therapeutics (Issuer)
Green Jeremy (Reporting)
Redmile Group, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
5:20 PM | Fate Therapeutics (Issuer)
Lee Michael Stewart (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
3:35 PM | Fate Therapeutics (Issuer)
RASTETTER WILLIAM H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
3:30 PM | Fate Therapeutics (Issuer)
Jooss Karin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
4:05 PM | Fate Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/10/2024
3:31 PM | Fate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2024
4:26 PM | Fate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/31/2024
4:24 PM | Fate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
8:01 AM | Fate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2024
11:15 PM | Fate Therapeutics (Filer)
| Form EFFECT | |
04/26/2024
3:16 PM | Fate Therapeutics (Filer)
| Form ARS | |
03/25/2024
8:30 PM | Fate Therapeutics (Issuer)
Green Jeremy (Reporting)
Redmile Group, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2024
4:15 PM | Fate Therapeutics (Subject)
Redmile Group, LLC (Filed by)
| Form SC 13D/A | |
03/20/2024
4:30 PM | Fate Therapeutics (Filer)
| Form 424B5 | |
03/04/2024
12:29 PM | Dulac Edward J III (Reporting)
Fate Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024
5:06 PM | Boxer Capital, LLC (Filed by)
Fate Therapeutics (Subject)
| Form SC 13G | |
02/09/2024
5:19 PM | Capital World Investors (Filed by)
Fate Therapeutics (Subject)
| Form SC 13G/A | |
01/30/2024
3:01 PM | Dulac Edward J III (Reporting)
Fate Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2024
12:44 PM | Dulac Edward J III (Reporting)
Fate Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/24/2024
8:46 AM | BlackRock Inc. (Filed by)
Fate Therapeutics (Subject)
| Form SC 13G/A | |
01/22/2024
12:46 PM | Fate Therapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/10/2024
3:29 PM | Dulac Edward J III (Reporting)
Fate Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2024
3:29 PM | Fate Therapeutics (Issuer)
Wolchko J Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2024
3:30 PM | Fate Therapeutics (Issuer)
Valamehr Bahram (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2024
3:30 PM | Fate Therapeutics (Issuer)
TAHL CINDY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
3:35 PM | Fate Therapeutics (Subject)
Valamehr Bahram (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/09/2024
3:36 PM | Fate Therapeutics (Subject)
TAHL CINDY (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/09/2024
3:36 PM | Dulac Edward J III (Reporting)
Fate Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/09/2024
3:39 PM | Fate Therapeutics (Subject)
Wolchko J Scott (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/02/2024
11:17 AM | Dulac Edward J III (Reporting)
Fate Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
The Tesla Trade Is Back In Business (Ad) If you held shares of Tesla throughout 2024, you know It’s been a year of extreme highs and lows…
But according to our one expert, new yearly highs are on the horizon…
In his words, Tesla is building momentum like in 2020, especially as Trump supports the EV maker.
Which is why we’re emailing you now…
You see, most people will simply buy shares of Tesla ahead of the election…
But as they say “There is more than one way to skin a cat”
In fact, we’ve found another way to play shares of Tesla. Discover how to trade Tesla, simply follow this link here. |
12/28/2023
8:30 PM | Fate Therapeutics (Issuer)
Green Jeremy (Reporting)
Redmile Group, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2023
3:53 PM | Fate Therapeutics (Subject)
| Form SC 13D/A | |
12/28/2023
3:53 PM | Fate Therapeutics (Subject)
Redmile Group, LLC (Filed by)
| Form SC 13D/A | |
12/18/2023
10:40 AM | Dulac Edward J III (Reporting)
Fate Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/27/2023
11:15 PM | Fate Therapeutics (Filer)
| Form EFFECT | |
